Skip to main content
. 2025 Aug 23;15:30992. doi: 10.1038/s41598-025-15360-7

Table 4.

The effects of PEG-rhG-CSF and rhG-CSF on long-term hematopoietic reconstitution and immune reconstitution at 6 months after ASCT.

PEG-rhG-CSF (n = 31) rhG-CSF (n = 35) p value

ANC, × 109/L (range)

Hemoglobin level, g/L (range)

PLTc, × 109/L (range)

2.9 (1.3–5.3)

127.3 (91–169)

153.1 (86–288)

3.1 (1.6–5.0)

124.7 (65–155)

141.9 (36–233)

0.386

0.586

0.397

Total lymphocyte count, /ul (range) 1082 (986.6–1215) 1162 (1013–1318) 0.397
CD4 + lymphocyte count, /ul (range) 217.7 (106–313.7) 344.4 (170–549.2) 0.313
CD8 + lymphocyte count, /ul (range) 509 (250.5–668.5) 598.4 (451.3–769.7) 0.498
CD19 + lymphocyte count, /ul (range) 178.1 (5.5–345.5) 188.9 (80.2–386.4) 0.930
CD3 + CD56 + lymphocyte count, /ul (range) 102.3 (5.3–167.2) 306.5 (34.3–955) 0.391
Immunoglobulin G, g/L (range) 9.6 (6.9–12.3) 11.0 (4.6–35.8) 0.686
Immunoglobulin A, g/L (range) 1.1 (0.3–2.1) 0.8 (0–1.6) 0.188
Immunoglobulin M, g/L (range) 0.5 (0.2–1.2) 0.6 (0–2.1) 0.602

ASCT, Autologous hematopoietic stem cell transplantation; PEG-rhG-CSF, Polyethylene glycolized recombinant human granulocyte-stimulating factor; rhG-CSF, Recombinant human granulocyte-stimulating factor; ANC, Absolute neutrophil count; LLN, Lower limit of normal; PLTc, Platelet count.